Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 12:12 AM
Ignite Modification Date:
2025-12-25 @ 12:12 AM
NCT ID:
NCT03911258
Eligibility Criteria:
Inclusion Criteria:
* Cystic fibrosis patients aged 0-20y followed in Cystic fibrosis at HUDERF
* For each participant, both parents or legally acceptable representative(s) must sign an informed consent form (ICF) indicating that they understand the purpose of, and procedures required for, the study and is willing to allow the child to participate in the study.
* Assent is also required of children capable of understanding the study (typically participants 7 years of age and older).
Exclusion Criteria:
Any clinical situation that prohibit the taking of samples as defined in this protocol:
* Severe respiratory distress
* An altered state of consciousness
* A pulmonary complication contrary to the realization of respiratory physiotherapy (pneumothorax, hemoptysis).
Healthy Volunteers:
False
Sex:
ALL
Maximum Age:
20 Years
Study:
NCT03911258
Study Brief:
Protocol Section:
NCT03911258